These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 26096811)

  • 21. Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy.
    Meo CD; Panza L; Capitani D; Mannina L; Banzato A; Rondina M; Renier D; Rosato A; Crescenzi V
    Biomacromolecules; 2007 Feb; 8(2):552-9. PubMed ID: 17291079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposome-based delivery of a boron-containing cholesteryl ester for high-LET particle-induced damage of prostate cancer cells: a boron neutron capture therapy study.
    Gifford I; Vreeland W; Grdanovska S; Burgett E; Kalinich J; Vergara V; Wang CK; Maimon E; Poster D; Al-Sheikhly M
    Int J Radiat Biol; 2014 Jun; 90(6):480-5. PubMed ID: 24605770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The radiation biology of boron neutron capture therapy.
    Coderre JA; Morris GM
    Radiat Res; 1999 Jan; 151(1):1-18. PubMed ID: 9973079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promising carboranylquinazolines for boron neutron capture therapy: synthesis, characterization, and in vitro toxicity evaluation.
    Genady AR
    Eur J Med Chem; 2009 Jan; 44(1):409-16. PubMed ID: 18407378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model.
    Yanagie H; Maruyama K; Takizawa T; Ishida O; Ogura K; Matsumoto T; Sakurai Y; Kobayashi T; Shinohara A; Rant J; Skvarc J; Ilic R; Kuhne G; Chiba M; Furuya Y; Sugiyama H; Hisa T; Ono K; Kobayashi H; Eriguchi M
    Biomed Pharmacother; 2006 Jan; 60(1):43-50. PubMed ID: 16260113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Boron neutron capture therapy for glioblastoma.
    Yamamoto T; Nakai K; Matsumura A
    Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trivalent galactosyl-functionalized mesoporous silica nanoparticles as a target-specific delivery system for boron neutron capture therapy.
    Lai CH; Lai NC; Chuang YJ; Chou FI; Yang CM; Lin CC
    Nanoscale; 2013 Oct; 5(19):9412-8. PubMed ID: 23958787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Facile Synthesis of Nido-Carborane Polymers via Dynamic Self-Assembly by Poly(carboxybetaine methacrylate).
    Wang Z
    J Nanosci Nanotechnol; 2021 Nov; 21(11):5681-5687. PubMed ID: 33980380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
    Yong JH; Barth RF; Wyzlic IM; Soloway AH; Rotaru JH
    Anticancer Res; 1995; 15(5B):2033-8. PubMed ID: 8572598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of Gd(III)-C-palmitamidomethyl-C'-DOTAMA-C(6)-o-carborane: a new dual agent for innovative MRI/BNCT applications.
    Aime S; Barge A; Crivello A; Deagostino A; Gobetto R; Nervi C; Prandi C; Toppino A; Venturello P
    Org Biomol Chem; 2008 Dec; 6(23):4460-6. PubMed ID: 19005608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rational design of gold nanoparticles functionalized with carboranes for application in Boron Neutron Capture Therapy.
    Ciani L; Bortolussi S; Postuma I; Cansolino L; Ferrari C; Panza L; Altieri S; Ristori S
    Int J Pharm; 2013 Dec; 458(2):340-6. PubMed ID: 24140178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Xylose as a carrier for boron containing compounds.
    Jacobsson M; Winander C; Mani K; Ellervik U
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2451-4. PubMed ID: 18325767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors.
    Liu L; Barth RF; Adams DM; Soloway AH; Reisfeld RA
    Anticancer Res; 1996; 16(5A):2581-7. PubMed ID: 8917355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COSAN as a molecular imaging platform: synthesis and "in vivo" imaging.
    Gona KB; Zaulet A; Gómez-Vallejo V; Teixidor F; Llop J; Viñas C
    Chem Commun (Camb); 2014 Oct; 50(77):11415-7. PubMed ID: 25130941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [18F]fluorination of o-carborane via nucleophilic substitution: towards a versatile platform for the preparation of 18F-labelled BNCT drug candidates.
    Gona KB; Gómez-Vallejo V; Padro D; Llop J
    Chem Commun (Camb); 2013 Dec; 49(98):11491-3. PubMed ID: 24175318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards new boron carriers for boron neutron capture therapy: metallacarboranes and their nucleoside conjugates.
    Leśnikowski ZJ; Paradowska E; Olejniczak AB; Studzińska M; Seekamp P; Schüssler U; Gabel D; Schinazi RF; Plesek J
    Bioorg Med Chem; 2005 Jul; 13(13):4168-75. PubMed ID: 15878666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folate receptor-mediated boron-10 containing carbon nanoparticles as potential delivery vehicles for boron neutron capture therapy of nonfunctional pituitary adenomas.
    Dai C; Cai F; Hwang KC; Zhou Y; Zhang Z; Liu X; Ma S; Yang Y; Yao Y; Feng M; Bao X; Li G; Wei J; Jiao Y; Wei Z; Ma W; Wang R
    Sci China Life Sci; 2013 Feb; 56(2):163-73. PubMed ID: 23334699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug delivery system design and development for boron neutron capture therapy on cancer treatment.
    Sherlock Huang LC; Hsieh WY; Chen JY; Huang SC; Chen JK; Hsu MH
    Appl Radiat Isot; 2014 Jun; 88():89-93. PubMed ID: 24447933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solution behavior of a sugar-based carborane for boron neutron capture therapy: a nuclear magnetic resonance investigation.
    Bonechi C; Ristori S; Martini S; Panza L; Martini G; Rossi C; Donati A
    Biophys Chem; 2007 Feb; 125(2-3):320-7. PubMed ID: 17079068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Closomers of high boron content: synthesis, characterization, and potential application as unimolecular nanoparticle delivery vehicles for boron neutron capture therapy.
    Ma L; Hamdi J; Wong F; Hawthorne MF
    Inorg Chem; 2006 Jan; 45(1):278-85. PubMed ID: 16390066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.